Organization: Health Canada
Year: 2020
Month: February
Request Number: A-2016-001759
Request Summary: The most current Risk Management Plan (RMP) and RMP review report for REMICADE (infliximab), Drug Identification Number (DIN) 02244016 by Janssen Inc.
Disposition: Disclosed in part
Number of pages: 699
Request a copy of records
Availability of records are subject to retention timelines as established by institutions. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act. For additional information, please see the “About Access to information and privacy” webpage.
Personal information that you provide is protected under the federal Privacy Act. Please do not include sensitive personal information in the message, such as your Social Insurance Number, personal finance data, medical or work history, or the personal information of other individuals.
Read the Privacy Statement for this page.
The collection and use of your personal information is authorized by the Financial Administration Act. Collection and use of your personal information for this site is in accordance with the federal Privacy Act. Your personal information is used to validate your use of GC datasets and for information on the development of the GC open data initiative, and may also be used to evaluate the effectiveness of the program in responding to client needs. In exceptional circumstances (e.g. network intrusion, or of individuals who make inappropriate remarks or threats, etc.), personal information may be disclosed without your consent pursuant to subsection 8(2) of the Privacy Act.
Any personal information that may be collected is described in the Standard Personal Information Banks entitled Public Communications, PSU 914, and Outreach Activities, PSU 938, which can be found in the Treasury Board of Canada Secretariat (TBS) publication: InfoSource.
Under the Privacy Act, you have the right of access to, and correction of, your personal information, if you have provided any. Note however, that to exercise either of these rights; you must make a request for access to your personal information. For more information about your right of access, please read about the Access to Information Program.
Any questions, comments, concerns or complaints you may have regarding this Statement, your privacy rights and the Privacy Act may be directed to the TBS Access to Information and Privacy Coordinator by email at atip.aiprp@tbs-sct.gc.ca or by calling 613-946-6260 or 1-866-312-1511. If you are not satisfied with TBS' response to your privacy concern, you may wish to contact the Office of the Privacy Commissioner by email at info@priv.gc.ca or by telephone at 1-800-282-1376. You have the right to complain to the Office of the Privacy Commissioner about TBS' handling of your personal information.